matrihealth is a spin-off of the Fraunhofer Institute for Microstructure of Materials and Systems IMWS. The team of matrihealth GmbH aims to make the potential of elastin accessible for the benefit of customers and patients in the different target markets. We bring elastin in high quality (medical grade) to the different markets. For this purpose, the team combines more than 20 years of combined R&D experience as well as profound expertise in the field of extracellular matrix composition in human tissue, especially the structure of the matrix proteins elastin and collagen.
The founding team of the matrihealth GmbH © Fraunhofer IMWS
The Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (FhG) is the largest organization for applied research and development services in Europe, employing some 29,000 people. With more than 74 institutes and facilities worldwide, FhG is a leader in applied research and development in almost all scientific and technical subject areas. With about 30 spin-offs per year, of which about 10% involve a direct participation of the FhG, the FhG has great experience in building technology-oriented start-ups and will contribute this knowledge for future spin-offs.
Together with the Fh-IMWS in Halle (Saale), the FhG is a shareholder in matrihealth GmbH and supports the core founding team with its expertise and network.
Tobias Hedtke © Fraunhofer IMWS
Tobias Hedtke studied biochemistry at Martin Luther University Halle-Wittenberg and graduated with a Master of Science degree at the end of 2016.
Since 2017, he has been working on his PhD at the Fraunhofer Institute for Microstructure of Materials and Systems IMWS and in the Biomedical Materials group of the Institute of Pharmacy at Martin Luther University Halle-Wittenberg.
Current research focuses on the investigation of the molecular structure and crosslinking pattern of elastin as well as its enzymatic damage. Furthermore, the development and characterization of biomaterials based on elastin and collagen with a focus on wound treatment and care is in the spotlight.
Marco Götze © Fraunhofer IMWS
Marco Götze studied mechanical engineering at Merseburg University of Applied Sciences and graduated in 2008. Since 2009 he has been working as a research assistant and since 2018 as a lecturer for additive manufacturing at Merseburg University and since 2019 at the Fraunhofer Institute for Microstructure of Materials and Systems.
Since 2015, he has been conducting research and completing his doctorate on the topic of laser processing of electrospun materials to improve their properties for regenerative medicine.
Dirk Schuster © Fraunhofer IMWS
Dirk Schuster holds a degree in business administration and worked in marketing and controlling at Deutsche Bank for over 14 years.
Since 2014, he has been a managing partner of several companies in the food sector. Due to his many years of experience as a managing director, his founding experience and competence in the commercial field, Mr. Schuster is responsible for the content-related focal points of marketing, sales, finance and personnel as managing director.
Chrisitan Schmelzer © Fraunhofer IMWS
After studying physical engineering and information processing, Christian Schmelzer earned his doctorate at the Department of Pharmacy at Martin Luther University Halle-Wittenberg (MLU). He then established a research group there dedicated to the formation and damage of elastic fibers, for which proteomics methods in particular were used.
From 2013 to 2014, he went to the Technion in Israel (Department of Biology) for a post-doctoral research stay in the field of immunology and then returned to MLU.
In 2016, Mr. Schmelzer moved to Fraunhofer IMWS, where he initially led the Fraunhofer Attract group SkinNext, which became the Biofunctional Materials for Medicine and Environment group in 2018.
Since 2018, he has been head of the Department of Biological and Macromolecular Materials at Fraunhofer IMWS.